Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122823 · ClinicalTrials.gov registry record · NA
Evaluation of the Online Chronic Disease Self-Management Project at Group Health
A NA study of Chronic Conditions, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 406
- Enrollment target
- 1
- Study location
NCT01122823: Completed NA study of Chronic Conditions, sponsored by Kaiser Permanente.
NCT01122823 is a NA study of Chronic Conditions that has completed, run by Kaiser Permanente. The registered enrollment target is 406 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01122823, a NA study of Chronic Conditions, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn if Group Health members who participate in the online chronic disease self-management program will experience improved health outcomes, improved health care utilization, and lower costs.
Primary Outcome
health status; self-efficacy; activities of daily living; symptomatology; mood; weight
Conditions Studied
Interventions
- BEHAVIORAL chronic disease self-management program (online)
Study Locations (1)
Washington
- Group Health Cooperative - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01122823 record still lists
NCT01122823 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Chronic Conditions appearing as the primary indexed condition, and to 1 intervention - of which chronic disease self-management program (online) is the first listed.
NCT01122823 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01122823 about?
NCT01122823 is a clinical study titled "Evaluation of the Online Chronic Disease Self-Management Project at Group Health". The purpose of this study is to learn if Group Health members who participate in the online chronic disease self-management program will experience improved health outcomes, improved health care utilization, and lower costs.
What is the current status of trial NCT01122823?
This trial is currently completed. It is a NA study. The enrollment target is 406 participants. The study started on 2009-02. Estimated completion is 2012-07.
What conditions does trial NCT01122823 study?
This clinical trial studies the following conditions: Chronic Conditions.
What interventions are being tested in trial NCT01122823?
The interventions under investigation include: chronic disease self-management program (online) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01122823?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01122823 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01122823's enrollment target sits among peer trials
406 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia